97 related articles for article (PubMed ID: 9013837)
21. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues.
Han AC; Peralta-Soler A; Knudsen KA; Wheelock MJ; Johnson KR; Salazar H
Hum Pathol; 1997 Jun; 28(6):641-5. PubMed ID: 9190996
[TBL] [Abstract][Full Text] [Related]
23. Immunoreactivity for the beta chain of the platelet-derived growth factor receptor in malignant mesothelioma and non-neoplastic mesothelium.
Ramael M; Buysse C; van den Bossche J; Segers K; van Marck E
J Pathol; 1992 May; 167(1):1-4. PubMed ID: 1320670
[TBL] [Abstract][Full Text] [Related]
24. Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.
Ahmed N; Riley C; Rice G; Quinn M
Clin Exp Metastasis; 2005; 22(5):391-402. PubMed ID: 16283482
[TBL] [Abstract][Full Text] [Related]
25. Value of the MOC-31 monoclonal antibody in differentiating epithelial pleural mesothelioma from lung adenocarcinoma.
Ordóñez NG
Hum Pathol; 1998 Feb; 29(2):166-9. PubMed ID: 9490276
[TBL] [Abstract][Full Text] [Related]
26. Value of the Ber-EP4 antibody in differentiating epithelial pleural mesothelioma from adenocarcinoma. The M.D. Anderson experience and a critical review of the literature.
Ordóñez NG
Am J Clin Pathol; 1998 Jan; 109(1):85-9. PubMed ID: 9426522
[TBL] [Abstract][Full Text] [Related]
27. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.
Padgett DM; Cathro HP; Wick MR; Mills SE
Am J Surg Pathol; 2008 Jan; 32(1):123-7. PubMed ID: 18162779
[TBL] [Abstract][Full Text] [Related]
28. Distribution of integrins and the extracellular matrix proteins in the baboon endometrium during the menstrual cycle and early pregnancy.
Fazleabas AT; Bell SC; Fleming S; Sun J; Lessey BA
Biol Reprod; 1997 Feb; 56(2):348-56. PubMed ID: 9116133
[TBL] [Abstract][Full Text] [Related]
29. Mesothelium expression of integrins in vivo and in vitro.
Witz CA; Montoya-Rodriguez IA; Miller DM; Schneider BG; Schenken RS
J Soc Gynecol Investig; 1998; 5(2):87-93. PubMed ID: 9509387
[TBL] [Abstract][Full Text] [Related]
30. [Malignant mesothelioma of the pleura. Analysis of its immunohistochemical aspects].
Chenard-Neu MP; Bellocq JP; Maier A; Batzenschlager A
Ann Pathol; 1990; 10(1):20-7. PubMed ID: 2328062
[TBL] [Abstract][Full Text] [Related]
31. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance.
Blobel GA; Moll R; Franke WW; Kayser KW; Gould VE
Am J Pathol; 1985 Nov; 121(2):235-47. PubMed ID: 2414994
[TBL] [Abstract][Full Text] [Related]
32. p53 immunostaining in the distinction between benign and malignant mesothelial proliferations using formalin-fixed paraffin sections.
Mayall FG; Goddard H; Gibbs AR
J Pathol; 1992 Dec; 168(4):377-81. PubMed ID: 1484319
[TBL] [Abstract][Full Text] [Related]
33. Expression of beta1 and beta4 integrins in normal arachnoid membrane and meningiomas.
Beschet I; Brunon J; Scoazec JY; Mosnier JF
Cancer; 1999 Dec; 86(12):2649-58. PubMed ID: 10594860
[TBL] [Abstract][Full Text] [Related]
34. Aspects of histopathologic subtype as a prognostic factor in 85 pleural mesotheliomas.
Johansson L; Lindén CJ
Chest; 1996 Jan; 109(1):109-14. PubMed ID: 8549169
[TBL] [Abstract][Full Text] [Related]
35. Immunoreactivity for p53 protein in malignant mesothelioma and non-neoplastic mesothelium.
Ramael M; Lemmens G; Eerdekens C; Buysse C; Deblier I; Jacobs W; van Marck E
J Pathol; 1992 Dec; 168(4):371-5. PubMed ID: 1484318
[TBL] [Abstract][Full Text] [Related]
36. The value of cytokeratins 20 and 7 in discriminating metastatic adenocarcinomas from pleural mesotheliomas.
Tot T
Cancer; 2001 Nov; 92(10):2727-32. PubMed ID: 11745209
[TBL] [Abstract][Full Text] [Related]
37. Severe chromosomal aberrations in pleural mesotheliomas with unusual mesodermal features. Comparative genomic hybridization evidence for a mesothelioma subgroup.
Krismann M; Müller KM; Jaworska M; Johnen G
J Mol Diagn; 2000 Nov; 2(4):209-16. PubMed ID: 11232111
[TBL] [Abstract][Full Text] [Related]
38. The calcium binding protein calretinin is a selective marker for malignant pleural mesotheliomas of the epithelial type.
Gotzos V; Vogt P; Celio MR
Pathol Res Pract; 1996 Feb; 192(2):137-47. PubMed ID: 8692714
[TBL] [Abstract][Full Text] [Related]
39. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
Brown RW; Clark GM; Tandon AK; Allred DC
Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
[TBL] [Abstract][Full Text] [Related]
40. Immunoreactivity for P-170 glycoprotein in malignant mesothelioma and in non-neoplastic mesothelium of the pleura using the murine monoclonal antibody JSB-1.
Ramael M; van den Bossche J; Buysse C; van Meerbeeck J; Segers K; Vermeire P; van Marck E
J Pathol; 1992 May; 167(1):5-8. PubMed ID: 1352542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
